Evo Fund lowers stake in Delta-Fly Pharma to 18.34%
Stake history
Summary
Evo Fund and joint holders filed a Change in 5%+ stake (change report) via EDINET on 2026-11-09 11:49 JST concerning Delta-Fly Pharma, Inc. Reported holding ratio: 18.34%, previous report: 19.39%.